A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension

Nephrology Dialysis Transplantation

Volumn 20, Issue 2, 2005, Pages 349-353

  Dussol, Bertrand ^a,b   Moussi Frances, Julie ^a   Morange, Sophie ^b   Somma Delpero, Claude ^c   Mundler, Oliver ^c   Berland, Yvon ^a,b  

^a HÔPITAL DE LA CONCEPTION   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

Fractional excretion; Furosemide; Hydrochlorothiazide; Hypertension; Renal failure; Sodium

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUORIDE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LONG ACTING DRUG; LOOP DIURETIC AGENT; SODIUM; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; ASTHENIA; BLOOD PRESSURE MEASUREMENT; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENTIATION; DRUG PREFERENCE; HUMAN; HYPERTENSION; HYPOKALEMIA; MALE; MEAN ARTERIAL PRESSURE; MUSCLE CRAMP; NEPHRON; POLYURIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM EXCRETION; STATISTICAL ANALYSIS; URINARY EXCRETION;

ADULT; AGED; CHLORIDES; CROSS-OVER STUDIES; DIURETICS; DOUBLE-BLIND METHOD; FUROSEMIDE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; SODIUM; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 14044251426     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh650     Document Type: Article

References (12)

1. Beretta-Piccoli C, Weidmann P, De Chatel R, Reubi F. Hypertension associated with early stage kidney disease. Complementary roles of circulating renin, the body sodium/volume state and duration of hypertension. Am J Med 1976; 61: 739-747
2. Klahr S, Levey A, Beck J et al., for the Modification of Diet in Renal Disease Study Group. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 1994; 330: 877-884
3. Hebert LA, Wilmer WA, Falkenhain ME, Ladson-Wofford SE, Nahman NS, Rovin BH. Renoprotection: one or many therapies. Kidney Int 2001; 59: 1211-1226
4. Wilcox CS. Diuretics. In Brenner BM, Rector FC, eds. The Kidney, 4th edn. W. B. Saunders Co., Philadelphia; 1991: 2123-2148
5. Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 1989; 36: 682-689
6. Kaissling B, Stanton BA. Adaptation of distal tubule and collecting duct to increased sodium delivery. I. Ultrastructure. Am J Physiol 1988; 255: F1256-F1268
7. + transport. Am J Physiol 1988; 255: F1269-F1275
8. Ellison DH. The physiological basis of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med 1991; 114: 886-894
9. Knauf H, Cawello W, Schmidt G, Mutschler E. The saturetic effect of the thiazide diuretic bemetizide in relation to the glomerular filtration rate. Eur J Clin Pharmacol 1994; 46: 9-13
10. Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. J Cardiovasc Pharmacol 1995; 26: 394-400
11. Dormans TPJ, Pickkers P, Russel FGM, Smits P. Vascular effects of loop diuretics. Cardiovasc Res 1996; 32: 988-997
12. Bennett WM. Thiazides for hypertension with renal failure. Lancet 1980; 1: 256